Vicarious Surgical Inc. (RBOT) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Vicarious Surgical Inc. (RBOT) Bundle
Discover the true potential of Vicarious Surgical Inc. (RBOT) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how these changes affect Vicarious Surgical Inc. (RBOT) valuation – all within one comprehensive Excel template.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -9.7 | -.2 | -34.8 | 7.3 | -69.2 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .1 | .2 | .3 | 1.9 | 1.9 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -9.8 | -.3 | -35.1 | 5.4 | -71.0 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 15.5 | 16.9 | 173.5 | 116.2 | 98.2 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | .2 | .4 | 1.5 | 1.7 | 1.3 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.2 | -.1 | -1.3 | -5.4 | -1.7 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -9.8 | -.3 | -34.0 | 92.6 | -71.0 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -9.7 | -.1 | -33.9 | 89.4 | -71.3 | -1.3 | .0 | .0 | .0 | .0 |
WACC, % | 8.41 | 8.41 | 8.38 | 8.41 | 8.41 | 8.4 | 8.4 | 8.4 | 8.4 | 8.4 |
PV UFCF | ||||||||||
SUM PV UFCF | -1.2 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -1 | |||||||||
Net Debt | -38 | |||||||||
Equity Value | 37 | |||||||||
Diluted Shares Outstanding, MM | 5 | |||||||||
Equity Value Per Share | 7.57 |
What You Will Get
- Editable Forecast Inputs: Seamlessly adjust assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Vicarious Surgical Inc.'s (RBOT) financial data pre-loaded to enhance your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing efficiency.
Key Features
- 🔍 Real-Life RBOT Financials: Pre-filled historical and projected data for Vicarious Surgical Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Vicarious Surgical’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Vicarious Surgical’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based RBOT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Vicarious Surgical Inc.'s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial decisions.
Why Choose This Calculator for Vicarious Surgical Inc. (RBOT)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your specific analysis.
- Real-Time Feedback: Observe immediate changes in Vicarious Surgical's valuation with every input adjustment.
- Preloaded Data: Comes equipped with Vicarious Surgical's actual financial information for swift evaluations.
- Preferred by Experts: Utilized by investors and analysts for making well-informed choices.
Who Should Use Vicarious Surgical Inc. (RBOT)?
- Surgeons: Enhance surgical precision with advanced robotic-assisted technology.
- Healthcare Providers: Streamline procedures and improve patient outcomes with innovative solutions.
- Investors: Gain insights into the future of surgical robotics and make informed investment choices.
- Medical Researchers: Explore cutting-edge developments in minimally invasive surgery.
- Students and Educators: Utilize the latest advancements in surgical technology for educational purposes.
What the Template Contains
- Pre-Filled DCF Model: Vicarious Surgical Inc.’s (RBOT) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Vicarious Surgical Inc.’s (RBOT) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.